SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced it has launched ...

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translational research, today announced that ...

PLEASANTON, Calif., May 17, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has won an injunction in its patent litigation ...

Bruker Corporation has emerged as the winner of an auction for NanoString Technologies and its spatial biology assets after the company filed for Chapter 11 bankruptcy earlier this year. The ...

Joe Beechem, PhD, CSO and senior vice president of research and development at NanoString Technologies is no stranger to the development of new genomic technologies. Moving from a substantial academic ...

Seattle's NanoString Technologies ($NSTG) stands to make up to $45 million if it can come up with a successful companion diagnostic test to screen for a subset of ...

Bruker (NASDAQ:BRKR) will buy NanoString Technologies, a Seattle-based innovator in gene expression profiling and spatial transcriptomics for ~$392.6M in cash, and the assumption of certain ...

NanoString, which has been acquired by Bruker, has won a victory in a patent battle with 10x Genomics. Billerica, MA-based Bruker said that the German Federal Patent Court has ruled in favor of ...

BILLERICA, Mass.--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) today announced that it has closed its asset acquisition of the business of NanoString Technologies, Inc., headquartered in ...